Results 211 to 220 of about 8,244 (227)

Delayed-onset eptifibatide-induced thrombocytopenia.

American Journal of Health-System Pharmacy, 2023
DISCLAIMER In an effort to expedite the publication of articles, AJHP is posting manuscripts online as soon as possible after acceptance. Accepted manuscripts have been peer-reviewed and copyedited, but are posted online before technical formatting and ...
Travis R. Huffman, Evan Gleaves, Glee Lenoir, Rahil Rafeedheen   +3 more
semanticscholar   +1 more source

Safety and efficacy of eptifibatide in acute ischemic stroke requiring extracranial carotid artery stenting.

Interventional Neuroradiology, 2023
BACKGROUND The antiplatelet management in acute ischemic stroke requiring carotid artery stenting is heterogenous, with no clear guidelines to direct management.
M. Waters, J. Vargas, A. Turk, I. Chaudry, R. Turner   +4 more
semanticscholar   +1 more source

Complications and Management of Eptifibatide-Induced Thrombocytopenia

The Annals of Pharmacotherapy, 2021
Background Eptifibatide is used in acute coronary syndromes to reversibly block platelet aggregation by inhibiting the platelet glycoprotein IIb/IIIa receptor.
Faisal Masood, Saad Hashmi, A. Chaus, Anna Hertsberg, E. Ehrenpreis   +4 more
semanticscholar   +1 more source

Safety and Efficacy of Periprocedural Bridging With Cangrelor Versus Eptifibatide

Journal of Cardiovascular Pharmacology, 2021
: Patients with percutaneous coronary interventions undergoing procedures often require interruptions in their dual antiplatelet therapy. Periprocedural bridging is considered for patients at high thrombotic risk using intravenous cangrelor, a reversible
Allison N. Yun, A. Toyoda, Edmond J. Solomon, R. Roberts, Christine S. Ji   +4 more
semanticscholar   +1 more source

Acute intraprocedural thrombosis during an arterial ductal stenting successfully managed by eptifibatide

Cardiology in the Young, 2021
Acute stent thrombosis may complicate neonatal arterial duct stenting for reduced pulmonary blood flow. Thrombolytic agents recanalise the clot but may cause bleeding around the vascular sheaths and other sites. Since early thrombus is platelet mediated,
Z. Mumtaz, K. Sivakumar
semanticscholar   +1 more source

Abstract WP25: Eptifibatide in Acute Ischemic Strokes Without Large Vessel Occlusions

Stroke
Background: Platelet glycoprotein IIb/IIIa inhibitors are currently being researched for patients with acute ischemic stroke (AIS), however there is no consensus on which inhibitor or dose is both safe and effective.
Subutay B. Bozkurt, Yong-Bum Song, Joshua Haimi, S. Sahito, Muhammad Nabeel Akbar, Paul Fanous, Ibrahim Abualnadi, Abdallah O Amireh, Michael Gates, Marriam Malik, Mariah Siddiqui, Nicholas Briski, sarah Abdelmessih, Yasemin Akinci, Kiapour Nazanin, Hubashia Khan, Nancy E Gadallah, N. Tabibzadeh, Sara Strauss, Arifa Ghori, S. Scarpiello, Thomas Snyder   +21 more
semanticscholar   +1 more source

Intravenous Argatroban or Eptifibatide in Patients Undergoing Mechanical Thrombectomy: A Subgroup Analysis of the MOST Randomized Clinical Trial.

JAMA Neurology
Importance The addition of direct thrombin inhibitors or glycoprotein platelet inhibitors to intravenous thrombolysis in patients undergoing endovascular thrombectomy for acute ischemic stroke may improve reperfusion rates and clinical outcomes ...
Ian Rines, O. Adeoye, Andrew D Barreto, Joseph P Broderick, J. Carrozzella, Hui Chen, Mauricio Concha, Jordan Elm, J. Grotta, Adam S Jasne, Pooja Khatri, Akash Roy, A. Vagal, M. Wintermark, Albert J. Yoo, Colin P. Derdeyn   +15 more
semanticscholar   +1 more source

Can Eptifibatide Rewrite the NSTEMI Story? (Eptifibatide vs. Standard Care for NSTEMI: A 5-Year Analysis of Major Adverse Cardiovascular Events).

Catheterization and cardiovascular interventions
BACKGROUND Coronary artery disease (CAD) is a leading cause of death worldwide. Among acute coronary syndromes, non-ST-elevation myocardial infarction (NSTEMI) poses a higher long-term risk than ST-elevation myocardial infarction (STEMI). Eptifibatide, a
Parvin Kalhor, Pargol Nowrouzi, Parichehr Ghahari, M. Mehrani   +3 more
semanticscholar   +1 more source

Abstract WP16: ROLE OF EPTIFIBATIDE IN POST-THROMBECTOMY STENOSIS

Stroke
Introduction: Currently, no level A evidence exists for the optimal rescue strategy for cases at high risk for re-occlusion following endovascular thrombectomy (EVT) in acute ischemic stroke.
Sivani Lingam, William Liu, Sabriya Sowers, Margaret Houghton, Laith N Maali   +4 more
semanticscholar   +1 more source

Thrombolysis Alone vs With Argatroban or Eptifibatide: A Prespecified Subgroup Analysis of the MOST Trial.

Neurology
BACKGROUND AND OBJECTIVES IV thrombolysis only (IVT-O) is the primary reperfusion therapy for most stroke patients. At least 50% of IVT-O patients remain disabled.
Akash Roy, Jordan Elm, James Ingles, Noor Sabagha, Josephine F Huang, Oladi Bentho, Tamra Ranasinghe, Christopher D Streib, Mauricio Concha, Pooja Khatri, A. Vagal, M. Wintermark, Colin P. Derdeyn, Joseph P. Broderick, Andrew D Barreto, O. Adeoye, J. Grotta   +16 more
semanticscholar   +1 more source